Conmed Corp (NYSE:CNMD)
$ 74.76 -0.88 (-1.16%) Market Cap: 2.31 Bil Enterprise Value: 3.24 Bil PE Ratio: 17.76 PB Ratio: 2.47 GF Score: 75/100

Conmed Corp to Discuss its Definitive Agreement to Acquire Biorez Inc - Conference Call Transcript

Aug 01, 2022 / 08:30PM GMT
Release Date Price: $97.57 (-0.06%)
Operator

Good afternoon, and welcome to the CONMED Corporation conference call. (Operator Instructions) Please note, this event is being recorded.

Before the conference call begins, let me remind you that during this call, management will be making comments and statements regarding its financial outlook and its plans and objectives, which represent forward-looking statements that involve risks and uncertainties as those terms are defined under the federal securities laws. Investors are cautioned that any such forward-looking statements are not guarantees of future events, performance or results, and the company's actual results may differ materially from its current expectations. Please refer to the risks and other uncertainties disclosed under forward-looking information in today's press release as well as the company's SEC filings for more details on the risks and uncertainties that may cause actual facts to differ materially. The company disclaims any obligation to update any forward-looking statements that may be discussed during this call, except as may be required by applicable law.

You'll

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot